Crossmark

Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors

Published Online: 2020-05-22

Authors

Arthur, Rachael https://orcid.org/0000-0002-3294-372X
Beatriz Valle-Argos, Beatriz https://orcid.org/0000-0003-3334-3387
Steele, Andrew J. https://orcid.org/0000-0003-0667-1596
Packham, Graham https://orcid.org/0000-0002-9232-5691
Funding

Funding for this research was provided by:

Cancer Research UK (C2750/A23669)
License Information

License valid from 2020-05-22
More Information

Publication History

Received: 2020-3-23

Accepted: 2020-4-24

Published Online: 2020-5-22

Document is current